Constrictive pericarditis future or investigational therapies

Jump to navigation Jump to search

Constrictive Pericarditis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Constrictive Pericarditis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Constrictive pericarditis future or investigational therapies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Constrictive pericarditis future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Constrictive pericarditis future or investigational therapies

CDC on Constrictive pericarditis future or investigational therapies

Constrictive pericarditis future or investigational therapies in the news

Blogs on Constrictive pericarditis future or investigational therapies

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Constrictive pericarditis future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hafiz M. Ahmed, M.D.[2]

Overview

There are no established future or investigational therapies specifically recommended for constrictive pericarditis in the 2025 ACC expert consensus statement. Current management emphasizes distinguishing inflammatory, potentially reversible constriction from chronic noninflammatory constriction, because this distinction guides anti-inflammatory therapy versus surgical pericardiectomy.

Future or Investigational Therapies

  • No investigational drug therapy is currently established specifically for constrictive pericarditis.
  • Future research may refine the role of multimodality imaging in identifying reversible inflammatory constriction and selecting patients for medical therapy versus pericardiectomy.
  • Novel risk models and machine learning approaches have been developed for recurrent pericarditis flare prediction, but these are not established therapies for constrictive pericarditis.[1]

References

  1. ↑ Wang TKM, Klein AL, Cremer PC, Imazio M, Kohnstamm S, Luis SA, Mardigyan V, Mukherjee M, Ordovas K, Vakamudi S, Wohlford GF. 2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on the Diagnosis and Management of Pericarditis: A Report of the American College of Cardiology Solution Set Oversight Committee. Journal of the American College of Cardiology. 2025;86(25):2691-2719. https://doi.org/10.1016/j.jacc.2025.05.023.

Template:WH Template:WS